Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials
October 09, 2024 08:00 ET
|
Evaxion Biotech
Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets Strongest outcomes are generated by the top-ranked...
2024 Research | Vaccine Delivery Devices Market Poised for Remarkable Growth, Expected to Reach $9.45 Billion by 2028
October 04, 2024 09:06 ET
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Delivery Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. In a significant development for the...
Human Combination Vaccines Market Through 2028
October 04, 2024 06:54 ET
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "Global Human Combination Vaccines Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The human combination vaccines market...
Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform
October 03, 2024 08:00 ET
|
Evaxion Biotech
Improved precision of the AI-Immunology™ platform in predicting clinically relevant vaccine targets boosts the potential of its AI-derived vaccine candidates The improvement has been achieved through...
Evaxion significantly expands vaccine development collaboration with MSD
September 26, 2024 07:30 ET
|
Evaxion Biotech
Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3Evaxion will host a conference call and webcast to discuss the agreement on...
mRNA Vaccine and Therapeutics Market Global Report to 2035, with Profiles of Arcturus Therapeutics, BioNTech, CureVac, Ethris, Immorna, Moderna, Providence Therapeutics and Suzhou Abogen Biosciences
September 26, 2024 07:21 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035: Distribution by Application Area, Target Disease Indication and...
Yellow Fever Vaccine Market Forecasted to Reach $5.56 Billion by 2028 - Global Long-term Forecast to 2033
September 26, 2024 04:10 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Yellow Fever Vaccine Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The yellow fever vaccine market has experienced...
Pneumococcal Vaccine Research Report 2024: Market Expected to Reach $12.932 Billion by 2029
September 25, 2024 10:22 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccines Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global pneumococcal...
New U.S. Department of Health and Human Services Campaign Joins HBCU Tour to Increase Flu, COVID-19 Vaccinations
September 10, 2024 12:21 ET
|
Risk Less. Do More. Pan Respiratory Virus Public Education Campaign
Milwaukee, Wis., Sept. 10, 2024 (GLOBE NEWSWIRE) -- The U.S. Department of Health and Human Services’ (HHS) Risk Less. Do More. campaign is partnering with the HBCU Tailgate Tour to increase...
$12.5 Bn Influenza Vaccine Market to 2032 by Vaccine Type, Technology, Age Group, Route of Administration, and Region
September 09, 2024 10:00 ET
|
Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Influenza Vaccine Market Report by Vaccine Type, Technology, Age Group, Route of Administration, and Region 2024-2032" report has been added to ...